Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A
Clinical trial NCT00621673 · TERMINATED
Trial details
- NCT number
- NCT00621673
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.